News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
495,006 Results
Type
Article (47670)
Company Profile (33)
Press Release (447303)
Multimedia
Podcasts (20)
Webinars (10)
Section
Business (139560)
Career Advice (1176)
Deals (26410)
Drug Delivery (82)
Drug Development (63692)
Employer Resources (92)
FDA (12868)
Job Trends (11333)
News (247554)
Policy (25619)
Tag
Academia (2720)
Academic (1)
Accelerated approval (5)
Adcomms (14)
Allergies (68)
Alliances (34098)
ALS (69)
Alzheimer's disease (1179)
Antibody-drug conjugate (ADC) (104)
Approvals (12899)
Artificial intelligence (173)
Autoimmune disease (14)
Automation (9)
Bankruptcy (275)
Best Places to Work (9085)
BIOSECURE Act (17)
Biosimilars (83)
Biotechnology (30)
Bladder cancer (68)
Brain cancer (27)
Breast cancer (234)
Cancer (1855)
Cardiovascular disease (140)
Career advice (962)
Career pathing (16)
CAR-T (131)
Cell therapy (338)
Cervical cancer (19)
Clinical research (51938)
Collaboration (635)
Compensation (165)
Complete response letters (24)
COVID-19 (2355)
CRISPR (29)
C-suite (203)
Cystic fibrosis (74)
Data (1898)
Decentralized trials (1)
Denatured (11)
Depression (35)
Diabetes (215)
Diagnostics (5028)
Digital health (9)
Diversity (7)
Diversity, equity & inclusion (29)
Drug discovery (82)
Drug pricing (78)
Drug shortages (16)
Duchenne muscular dystrophy (79)
Earnings (52972)
Editorial (21)
Employer branding (11)
Employer resources (81)
Events (59986)
Executive appointments (627)
FDA (13910)
Friedreich's ataxia (1)
Frontotemporal dementia (6)
Funding (537)
Gene editing (74)
Generative AI (14)
Gene therapy (223)
GLP-1 (519)
Government (3503)
Grass and pollen (3)
Guidances (52)
Healthcare (14776)
Huntington's disease (15)
IgA nephropathy (23)
Immunology and inflammation (84)
Indications (27)
Infectious disease (2469)
Inflammatory bowel disease (114)
Inflation Reduction Act (8)
Influenza (44)
Intellectual property (88)
Interviews (191)
IPO (13283)
IRA (27)
Job creations (2553)
Job search strategy (840)
Kidney cancer (10)
Labor market (23)
Layoffs (363)
Leadership (6)
Legal (6390)
Liver cancer (57)
Lung cancer (278)
Lymphoma (132)
Machine learning (5)
Management (25)
Manufacturing (249)
MASH (57)
Medical device (10080)
Medtech (10082)
Mergers & acquisitions (13619)
Metabolic disorders (520)
Multiple sclerosis (72)
NASH (14)
Neurodegenerative disease (73)
Neuropsychiatric disorders (18)
Neuroscience (1615)
NextGen: Class of 2025 (4903)
Non-profit (3566)
Now hiring (18)
Obesity (250)
Opinion (89)
Ovarian cancer (71)
Pain (74)
Pancreatic cancer (73)
Parkinson's disease (121)
Partnered (19)
Patents (202)
Patient recruitment (90)
Peanut (40)
People (45034)
Pharmaceutical (13)
Pharmacy benefit managers (17)
Phase I (15548)
Phase II (22913)
Phase III (17793)
Pipeline (1046)
Policy (99)
Postmarket research (1932)
Preclinical (6611)
Press Release (42)
Prostate cancer (89)
Psychedelics (25)
Radiopharmaceuticals (203)
Rare diseases (279)
Real estate (4495)
Recruiting (36)
Regulatory (17490)
Reports (27)
Research institute (2002)
Resumes & cover letters (196)
Rett syndrome (4)
RNA editing (2)
RSV (35)
Schizophrenia (59)
Series A (80)
Series B (50)
Service/supplier (5)
Sickle cell disease (41)
Special edition (10)
Spinal muscular atrophy (118)
Sponsored (21)
Startups (2379)
State (2)
Stomach cancer (8)
Supply chain (47)
Tariffs (16)
The Weekly (9)
Vaccines (599)
Venture capitalists (20)
Weight loss (160)
Women's health (23)
Worklife (5)
Date
Today (127)
Last 7 days (641)
Last 30 days (1936)
Last 365 days (25218)
2025 (8026)
2024 (27245)
2023 (30982)
2022 (38259)
2021 (44351)
2020 (43123)
2019 (34770)
2018 (26802)
2017 (24732)
2016 (22797)
2015 (27284)
2014 (19935)
2013 (16812)
2012 (17922)
2011 (18577)
2010 (16812)
Location
Africa (529)
Alabama (47)
Alaska (5)
Arizona (123)
Arkansas (11)
Asia (29887)
Australia (5142)
California (4485)
Canada (1657)
China (403)
Colorado (219)
Connecticut (221)
Delaware (103)
Europe (63499)
Florida (761)
Georgia (153)
Idaho (40)
Illinois (414)
India (16)
Indiana (241)
Iowa (9)
Japan (130)
Kansas (88)
Kentucky (17)
Louisiana (8)
Maine (50)
Maryland (618)
Massachusetts (3000)
Michigan (188)
Minnesota (236)
Mississippi (2)
Missouri (63)
Montana (26)
Nebraska (14)
Nevada (60)
New Hampshire (56)
New Jersey (1434)
New Mexico (16)
New York (1424)
North Carolina (742)
North Dakota (4)
Northern California (1959)
Ohio (143)
Oklahoma (13)
Oregon (19)
Pennsylvania (1059)
Puerto Rico (11)
Rhode Island (23)
South America (792)
South Carolina (18)
South Dakota (1)
Southern California (1736)
Tennessee (91)
Texas (744)
United States (17242)
Utah (137)
Virginia (123)
Washington D.C. (47)
Washington State (456)
West Virginia (3)
Wisconsin (33)
495,006 Results for "michigan state university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Breakthrough T1D Awards $2.8 Million in Funding to Expand Center of Excellence at University of Michigan and Oregon Health & Science University to Accelerate Type 1 Diabetes Research
April 24, 2025
·
5 min read
Pharm Country
NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan
NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that the University of Michigan will begin the pilot phase of its clinical trial of UroShield this week.
May 22, 2024
·
4 min read
Press Releases
NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan
January 7, 2025
·
4 min read
BioMidwest
Centene Subsidiary Meridian in Michigan Awarded Michigan Medicaid Contracts
Centene Corporation announced that its subsidiary, Meridian in Michigan, has been selected by the Michigan Department of Health and Human Services to continue to serve as a Medicaid health plan for the Comprehensive Health Care Program, which serves nearly 2 million Michiganders statewide.
April 9, 2024
·
10 min read
Business
Walden Biosciences Expands Research Collaboration with the University of Michigan
Walden Biosciences, Inc. today announced that it has broadened its research collaboration with the University of Michigan at Ann Arbor (U-M).
January 10, 2024
·
3 min read
Press Releases
Vera Therapeutics Partners with University of Michigan on the NEPTUNE Match Project and PIONEER Study
November 11, 2024
·
7 min read
Business
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
NanoVibronix, Inc. today announced it has signed a Research Agreement with the Regents of the University of Michigan for a Randomized Control Trial (“RCT”) study of UroShield.
November 28, 2023
·
4 min read
Genetown
Activated University of Michigan as The Second Site for Clinical Trial in Severe Esophageal Disease
Harvard Apparatus Regenerative Technology, Inc. announced that it officially activated the second site with University of Michigan for its clinical trial as to severe esophageal disease, being its first clinical trial in the United States.
August 28, 2023
·
4 min read
Business
Tryp Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial for the Treatment of Fibromyalgia at The University of Michigan
Tryp Therapeutics Inc. is pleased to announce that the first patient has been dosed in a Phase 2a clinical trial being conducted by the University of Michigan in a collaboration with Tryp Therapeutics.
January 4, 2024
·
5 min read
Drug Development
ASPIRE-FTD Phase 1/2 Clinical Trial Opens in the U.S. at The Ohio State University Wexner Medical Center
AviadoBio today announced that its Phase 1/2 ASPIRE-FTD clinical trial is now open and recruiting patients in the United States at The Ohio State University.
July 1, 2024
·
7 min read
1 of 49,501
Next
